Science Explorer Back to mapMap

Most cited papers from Instituto Nacional del Cáncer

What are the most cited papers from Instituto Nacional del Cáncer?

The most cited paper from Instituto Nacional del Cáncer is "Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial" (Ian F. Tannock et al., 2013), with 289 citations. Next come "Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study" (179) and "Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01)" (156).

Showing 50 of 61 papers. Every paper with more than 32 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Aflibercept versus placebo in combination with docetaxel and prednisone for treatment of men with metastatic castration-resistant prostate cancer (VENICE): a phase 3, double-blind randomised trial Ian F. Tannock et al. · The Lancet Oncology 3 Jun 2013 289
2 Effects of Parenteral Hydration in Terminally Ill Cancer Patients: A Preliminary Study Eduardo D Bruera, Raúl Sala, María Antonieta Rico et al. · Journal of Clinical Oncology 30 Mar 2005 179
3 Phase III Trial of Adjuvant Capecitabine After Standard Neo-/Adjuvant Chemotherapy in Patients With Early Triple-Negative Breast Cancer (GEICAM/2003-11_CIBOMA/2004-01) Ana M. Lluch et al. · Journal of Clinical Oncology Open access 5 Dec 2019 156
4 Assessment of BRAFV600E and SMOF412E mutations in epithelial odontogenic tumours Marina Gonçalves Diniz, Carolina Cavaliéri Gomes, Bruna Viana Antonini Guimarães et al. · Tumor Biology 17 Feb 2015 126
5 Cancer control in Latin America and the Caribbean: recent advances and opportunities to move forward Carlos H. Barrios et al. · The Lancet Oncology Nov 2021 117
6 Gallstones, Body Mass Index, C‐Reactive Protein, and Gallbladder Cancer: Mendelian Randomization Analysis of Chilean and European Genotype Data Carol Barahona Ponce et al. · Hepatology Open access 24 Sep 2020 108
7 Dexamethasone in addition to metoclopramide for chronic nausea in patients with advanced cancer: a randomized controlled trial Eduardo D Bruera, Jario Ricardo Moyano, Raúl Sala et al. · Journal of Pain and Symptom Management Open access Oct 2004 102
8 Infant Acute Leukemia and Maternal Exposures during Pregnancy Maria S. Pombo‐de‐Oliveira, Sérgio Koifman, Brazilian Collaborative Study Group of Infant Acute Leukemia · Cancer Epidemiology Biomarkers & Prevention Dec 2006 101
9 Nintedanib plus pemetrexed versus placebo plus pemetrexed in patients with relapsed or refractory, advanced non-small cell lung cancer (LUME-Lung 2): A randomized, double-blind, phase III trial Nasser H. Hanna, Rolf Kaiser, Richard N. Sullivan et al. · Lung Cancer 27 Oct 2016 88
10 Geological investigation of the Yahgan Formation (Upper Mesozoic) and associated igneous rocks of Navarino Island, Southern Chile H. R. Katz, W. A. Watters · New Zealand Journal of Geology and Geophysics Open access Oct 1966 88
11 Positive correlation between single or combined genotypes of CYP1A1 and GSTM1 in relation to prostate cancer in Chilean people Cristián Acevedo, Jose Luis Opazo, Christian Huidobro et al. · The Prostate Open access 27 Aug 2003 81
12 Epidemiology of Hematologic Malignancies in Real-World Settings: Findings From the Hemato-Oncology Latin America Observational Registry Study Vania Tietsche de Moraes Hungria et al. · Journal of Global Oncology Open access 27 Nov 2019 78
13 Propiedades psicométricas de la Escala Hospitalaria de Ansiedad y Depresión (HADS) en una población de pacientes oncológicos mexicanos Óscar Galindo, Facultad de Psicología, Universidad Nacional Autónoma de México., Servicio de Psico-oncología, Instituto Nacional de Cancerología. et al. · Salud Mental Open access 20 Aug 2015 72
14 Subtypes of Native American ancestry and leading causes of death: Mapuche ancestry-specific associations with gallbladder cancer risk in Chile Justo Lorenzo Bermejo et al. · PLoS Genetics Open access 25 May 2017 70
15 Association of single nucleotide polymorphisms in Pre-miR-27a, Pre-miR-196a2, Pre-miR-423, miR-608 and Pre-miR-618 with breast cancer susceptibility in a South American population Sebastián Morales, Felipe Gulppi, Patricio González‐Hormazábal et al. · BMC Genetics Open access 14 Jul 2016 69
16 Low‐grade regional metamorphism in the Mesozoic‐Cenozoic volcanic sequences of the Central Andes Beatriz Levi, Luis Aguirre, Jan Olov Nyström et al. · Journal of Metamorphic Geology Sep 1989 66
17 ADAR1-mediated RNA-editing of 3′UTRs in breast cancer Eduardo A. Sagredo, Alejandro Blanco, Alfredo I. Sagredo et al. · Biological Research Open access 5 Oct 2018 65
18 Incidence of BRCA1 and BRCA2 mutations in 54 Chilean families with breast/ovarian cancer, genotype–phenotype correlations Marcela Gallardo, Antônia Silva, Lorena Rubio et al. · Breast Cancer Research and Treatment 27 Oct 2005 65
19 Calculation of beam quality correction factors for various thimble ionization chambers using the Monte Carlo code PENELOPE Fabián Erazo, Antonio Miguel Lallena · Physica Medica 29 Jan 2012 64
20 Craniofacial Resection for Malignant Melanoma of the Skull Base Ian Ganly et al. · Archives of Otolaryngology - Head and Neck Surgery 2006 61
21 Effects of serine protease inhibitors on viability and morphology of Leishmania (Leishmania) amazonensis promastigotes Raquel Elisa da Silva-López, José Andrés Morgado‐Díaz, Maria Angeles Chavez et al. · Parasitology Research 28 Aug 2007 61
22 Occupation and the risk of lung cancer in Uruguay E De Stéfani, Manolis Kogevinas, Paolo Boffetta et al. · Scandinavian Journal of Work Environment & Health Open access Oct 1996 60
23 Humanização e cuidados paliativos Márcia Fróes Skaba · Ciência & Saúde Coletiva Open access Sep 2005 59
24 Avelumab Versus Docetaxel in Patients With Platinum-Treated Advanced NSCLC: 2-Year Follow-Up From the JAVELIN Lung 200 Phase 3 Trial Keunchil Park, Mustafa Özgüroğlu, Johan Vansteenkiste et al. · Journal of Thoracic Oncology Open access 9 Apr 2021 56
25 Epigenome‐Wide Analysis of Methylation Changes in the Sequence of Gallstone Disease, Dysplasia, and Gallbladder Cancer Johannes Brägelmann et al. · Hepatology Open access 5 Oct 2020 56
26 Understanding tumor anabolism and patient catabolism in cancer-associated cachexia. Alejandro Schcolnik‐Cabrera, Alma Delia Chávez-Blanco, Guadalupe Domínguez-Gómez et al. · PubMed Open access 2017 56
27 Vegetables, fruits, and risk of colorectal cancer: A case‐control study from Uruguay Hugo Deneo‐Pellegrini, Eduardo De Stéfani, Álvaro L. Ronco · Nutrition and Cancer 1996 55
28 Is There a Role for Peptide Receptor Radionuclide Therapy in Medullary Thyroid Cancer? Fernanda Vaisman, Paulo Henrique Rosado-de-Castro, Flávia Paiva Proença Lobo Lopes et al. · Clinical Nuclear Medicine 30 Dec 2014 54
29 Tobacco, Alcohol, Diet and Risk of prostate Cancer Eduardo De Stéfani, Luis Fierro, Enrique Barrios et al. · Tumori Journal Sep 1995 53
30 Multiple myeloma treatment patterns and clinical outcomes in the Latin America Haemato‐Oncology (HOLA) Observational Study, 2008–2016 Vania Tietsche de Moraes Hungria, Deborah M. Martinez-Banos, Christian Omar Ramos Peñafiel et al. · British Journal of Haematology Open access 7 Aug 2019 51
31 Naphthoquinone-based chalcone hybrids and derivatives: synthesis and potent activity against cancer cell lines Guilherme A. M. Jardim, Tiago T. Guimarães, Maria do Carmo F. R. Pinto et al. · MedChemComm Open access 24 Sep 2014 51
32 Comparison of the cytotoxic effect of lapachol, α-lapachone and pentacyclic 1,4-naphthoquinones on human leukemic cells Eduardo J. Salustiano, Chaquip D. Netto, Renata F. Fernandes et al. · Investigational New Drugs 2 Mar 2009 51
33 Cancer registration for cancer control in Latin America: a status and progress report. Marion Piñeros, María Graciela Abriata, Les Mery et al. · PubMed Open access 2017 50
34 Association of social network and social support with health-related quality of life and fatigue in long-term survivors of Hodgkin lymphoma Andrea Ribeiro Soares, Irène Biasoli, Adriana Alves de Souza Scheliga et al. · Supportive Care in Cancer 8 Mar 2013 47
35 Chalcone-Induced Apoptosis through Caspase-Dependent Intrinsic Pathways in Human Hepatocellular Carcinoma Cells Rodrigo Ramírez‐Tagle, Carlos A. Escobar, Valentina Romero et al. · International Journal of Molecular Sciences Open access 22 Feb 2016 45
36 Variants in DNA double-strand break repair genes and risk of familial breast cancer in a South American population Lilian Jara, Karen Dubois‐Camacho, Daniel Gaete et al. · Breast Cancer Research and Treatment Open access 6 Jan 2010 45
37 A detecção precoce do câncer de mama e a interpretação dos resultados de estudos de sobrevida Arn Migowski · Ciência & Saúde Coletiva Open access Apr 2015 44
38 RAD51 135G>C polymorphism and risk of familial breast cancer in a South American population Lilian Jara, Mónica L. Acevedo, Rafael Blanco et al. · Cancer Genetics and Cytogenetics Open access 22 Sep 2007 44
39 Spectrum of BRCA1/2 point mutations and genomic rearrangements in high-risk breast/ovarian cancer Chilean families Patricio González‐Hormazábal, Sara Gutiérrez‐Enríquez, Daniel Gaete et al. · Breast Cancer Research and Treatment 21 Sep 2010 42
40 A Risk Score to Predict Admission to the Intensive Care Unit in Patients with COVID-19: the ABC-GOALS score Juan Manuel Mejia-Vilet, Bertha M. Córdova‐Sánchez, Dheni Aidé Fernández-Camargo et al. · Salud Pública de México Open access 11 Sep 2020 39
41 Clinical and demographic characteristics of Epstein-Barr virus-associated childhood Burkitt's lymphoma in Southeastern Brazil: epidemiological insights from an intermediate risk region Rocı́o Hassan, Claudete Esteves Klumb, Fabricio Felisbino et al. · Haematologica Open access 27 Mar 2008 39
42 Genetic variants in FGFR2 and MAP3K1 are associated with the risk of familial and early-onset breast cancer in a South-American population Lilian Jara, Patricio González‐Hormazábal, Kerube Cerceño et al. · Breast Cancer Research and Treatment Open access 6 Dec 2012 39
43 Expression of survivin protein in pterygium and relationship with oxidative DNA damage Cristina Maxia, Maria Teresa Perra, P Demurtas et al. · Journal of Cellular and Molecular Medicine Open access 6 Feb 2008 39
44 Association Between Tumor Egfr and Kras Mutation Status and Clinical Outcomes in Nsclc Patients Randomized to Sorafenib Plus Best Supportive Care (BSC) or Bsc Alone: Subanalysis of the Phase III Mission Trial Tony S.K. Mok, Luis G Paz-Ares, Yi-Long Lung Cancer Wu et al. · Annals of Oncology Open access Sep 2012 38
45 Genome-wide methylation profiling reveals Zinc finger protein 516 (ZNF516) and FK-506-binding protein 6 (FKBP6) promoters frequently methylated in cervical neoplasia, associated with HPV status and ethnicity in a Chilean population Priscilla Brebi, Leonel Maldonado, Maartje G. Noordhuis et al. · Epigenetics Open access 15 Nov 2013 36
46 Association of common ATMvariants with familial breast cancer in a South American population Patricio González‐Hormazábal, Teresa Bravo, Rafael Blanco et al. · BMC Cancer Open access 23 Apr 2008 36
47 A Review of Recent Data in the Treatment of Gallbladder Cancer: What We Know, What We Do, and What Should Be Done Bettina Müller, Xabier de Aretxabala, Manuel González Domingo · American Society of Clinical Oncology Educational Book May 2014 35
48 Tumores del estroma gastrointestinal (GIST), un particular tipo de neoplasia Pablo Bórquez M, Rodrigo Neveu C · Revista médica de Chile Open access Jul 2008 35
49 Characterization ofLGALS3(galectin-3) as a player in DNA damage response Renato Sampaio Carvalho, Vanessa Camara Fernandes, Thales C. Nepomuceno et al. · Cancer Biology & Therapy Open access 22 Apr 2014 35
50 Mutational Profile and New IASLC/ATS/ERS Classification Provide Additional Prognostic Information about Lung Adenocarcinoma: A Study of 125 Patients from Brazil Andréia Cristina de Melo, Vanessa Karen de Sá, Cinthya Sternberg et al. · Oncology 2015 35

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.